0 NASDAQ Companies - March 4, 2019PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiology’s 68th Annual Scientific SessionRead More
0 NASDAQ Companies - March 4, 2019The Joint Corp. to Present at the 31st Annual ROTH ConferenceRead More
0 NASDAQ Companies - March 4, 2019Krystal Strengthens Board of Directors with Appointment of Julian S. GangolliRead More
0 NASDAQ Companies - March 4, 2019IPG Photonics Honored with Multiple Awards in 2019 Lightwave Innovation Reviews ProgramRead More
0 NASDAQ Companies - March 4, 2019Enphase Energy and Erus Energy Celebrate Ten Years of Solar CollaborationRead More
0 NASDAQ Companies - March 4, 2019Telia Carrier and Infinera Demonstrate Industry-first Autonomous Intelligent Transponder in Live Network Field TrialRead More
0 NASDAQ Companies - March 4, 2019MYnd Analytics and Arcadian Telepsychiatry Services Announce Partnership with IMPACT Solutions to Provide Tele-EAP ServicesRead More
0 NASDAQ Companies - March 4, 2019Acacia Communication’s Pico DSP and AC1200 Builds Industry Momentum with OFC Customer Demonstrations, Field Trials and Industry RecognitionRead More
0 NASDAQ Companies - March 4, 2019Esperion Announces Presentation of Bempedoic Acid Pivotal Phase 3 Study 2 Results in a Late-Breaking Clinical Trial Session at the American College of Cardiology 2019 Scientific SessionsRead More
